Literature DB >> 4048170

Mast cells and their degranulation in the Tsk mouse model of scleroderma.

M Walker, R Harley, J Maize, F DeLustro, E C LeRoy.   

Abstract

The Tsk mouse is a genetically transmitted example of cutaneous fibrosis which has been compared with human scleroderma. During a systematic histopathological study of the Tsk mouse, both an increased number and an increased proportion of degranulated mast cells were observed. The consistent association of mast cells and fibrosis in scleroderma, graft-vs-host reactions (GVHR), and now the Tsk mouse raises the question of a pathogenetic role for mast cells in fibrotic disorders in general.

Entities:  

Mesh：

Year:  1985        PMID： 4048170     DOI： 10.3181/00379727-180-42183

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


  9 in total

Review 1.  The Importance of Mast Cells in Dermal Scarring.

Authors:  Traci A Wilgus; Brian C Wulff
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-04-01       Impact factor: 4.730

2.  Effect of mast cell chymase inhibitor on the development of scleroderma in tight-skin mice.

Authors:  Naotaka Shiota; Eiichi Kakizoe; Keiko Shimoura; Tetsuya Tanaka; Hideki Okunishi
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

3.  Granulated metrial gland cells in the pregnant uterus of mice expressing the collagen mutation tight-skin (Tsk/+).

Authors:  Y Kiso; B A McBey; B A Croy
Journal:  Cell Tissue Res       Date:  1992-05       Impact factor: 5.249

Review 4.  Mast cells and immunological skin diseases.

Authors:  Daniel Navi; Jun Saegusa; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

5.  Mast cell activation and migration to lymph nodes during induction of an immune response in mice.

Authors:  H W Wang; N Tedla; A R Lloyd; D Wakefield; P H McNeil
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

6.  Anti-IgE autoantibodies in systemic sclerosis (scleroderma).

Authors:  L D Kaufman; B L Gruber; M J Marchese; J R Seibold
Journal:  Ann Rheum Dis       Date:  1989-03       Impact factor: 19.103

7.  The use of streptolysin o for the treatment of scars, adhesions and fibrosis: initial investigations using murine models of scleroderma.

Authors:  Stephen W Mamber; Vit Long; Ryan G Rhodes; Sunthorn Pond-Tor; Lyn R Wheeler; Kellie Fredericks; Brian Vanscoy; Jean-Frederic Sauniere; Remy Steinschneider; Jean-Claude Laurent; John McMichael
Journal:  Nonlinearity Biol Toxicol Med       Date:  2004-04

Review 8.  A Review of the Evidence for and against a Role for Mast Cells in Cutaneous Scarring and Fibrosis.

Authors:  Traci A Wilgus; Sara Ud-Din; Ardeshir Bayat
Journal:  Int J Mol Sci       Date:  2020-12-18       Impact factor: 5.923

9.  Mast Cell Activation in the Systemic Sclerosis Esophagus.

Authors:  Kevin Tom; Bhaven K Mehta; Aileen Hoffmann; Kathleen Aren; Mary Carns; Jungwha Lee; Viktor Martyanov; Dillon Popovich; Noelle Kosarek; Tammara Wood; Darren Brenner; Dustin A Carlson; Lorena Ostilla; Emma Willcocks; Paul Bryce; Joshua B Wechsler; Michael L Whitfield; Monique Hinchcliff
Journal:  J Scleroderma Relat Disord       Date:  2020-07-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.